Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Ovarian Neoplasms

  Free Subscription


29.08.2022

1 Am J Obstet Gynecol
1 Clin Cancer Res
1 Discov Oncol
1 Int J Oncol
1 J Clin Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Obstet Gynecol

  1. BODURTHA SMITH AJ, Alvarez R, Heintz J, Haggerty A, et al
    Disparities in Biomarker Testing in Ovarian Cancer: A Real-World Analysis.
    Am J Obstet Gynecol. 2022 Aug 22. pii: S0002-9378(22)00686.
    PubMed        


    Clin Cancer Res

  2. WIMBERGER P, Gerber MJ, Pfisterer J, Erdmann K, et al
    Bevacizumab may differentially improve prognosis of advanced ovarian cancer patients with low expression of VEGF-A165b, an anti-angiogenic VEGF-A splice variant.
    Clin Cancer Res. 2022 Aug 24. pii: 708584. doi: 10.1158/1078-0432.CCR-22-1326.
    PubMed         Abstract available


    Discov Oncol

  3. SHEN J, Tao Y, He L, Guan H, et al
    Clinical application of radiotherapy in patients with oligometastatic ovarian cancer: a sharp tool to prolong the interval of systemic treatment.
    Discov Oncol. 2022;13:82.
    PubMed         Abstract available


    Int J Oncol

  4. LI R, Wang Y, Xu Y, He X, et al
    [Retracted] Silencing the long noncoding RNA, TINCR, a molecular sponge of miR335, inhibits the malignant phenotype of epithelial ovarian cancer via FGF2 suppression.
    Int J Oncol. 2022;61.
    PubMed         Abstract available


    J Clin Oncol

  5. SPILSBURY K, Tuesley KM, Pearson SA, Coory MD, et al
    Perioperative Beta-Blocker Supply and Survival in Women With Epithelial Ovarian Cancer and a History of Cardiovascular Conditions.
    J Clin Oncol. 2022 Aug 24:JCO2200097. doi: 10.1200/JCO.22.00097.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: